nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—RXRA—prostate cancer	0.386	0.873	CbGaD
Bexarotene—CYP3A4—prostate cancer	0.0563	0.127	CbGaD
Bexarotene—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0346	0.126	CbGbCtD
Bexarotene—CYP2C9—Nilutamide—prostate cancer	0.0312	0.114	CbGbCtD
Bexarotene—CYP2C9—Bicalutamide—prostate cancer	0.0312	0.114	CbGbCtD
Bexarotene—CYP2C9—Estrone—prostate cancer	0.0187	0.0685	CbGbCtD
Bexarotene—CYP3A4—Bicalutamide—prostate cancer	0.0182	0.0664	CbGbCtD
Bexarotene—CYP3A4—Estramustine—prostate cancer	0.0169	0.0618	CbGbCtD
Bexarotene—CYP3A4—Flutamide—prostate cancer	0.0151	0.0551	CbGbCtD
Bexarotene—CYP3A4—Abiraterone—prostate cancer	0.0151	0.0551	CbGbCtD
Bexarotene—CYP2C9—Capecitabine—prostate cancer	0.0142	0.0519	CbGbCtD
Bexarotene—CYP3A4—Cabazitaxel—prostate cancer	0.0111	0.0407	CbGbCtD
Bexarotene—CYP3A4—Estrone—prostate cancer	0.0109	0.0398	CbGbCtD
Bexarotene—CYP2C9—Estradiol—prostate cancer	0.0107	0.0393	CbGbCtD
Bexarotene—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0097	0.0355	CbGbCtD
Bexarotene—CYP3A4—Conjugated Estrogens—prostate cancer	0.00712	0.026	CbGbCtD
Bexarotene—CYP3A4—Mitoxantrone—prostate cancer	0.00647	0.0237	CbGbCtD
Bexarotene—CYP3A4—Estradiol—prostate cancer	0.00625	0.0229	CbGbCtD
Bexarotene—CYP3A4—Prednisone—prostate cancer	0.00537	0.0197	CbGbCtD
Bexarotene—CYP3A4—Etoposide—prostate cancer	0.00408	0.0149	CbGbCtD
Bexarotene—CYP3A4—Docetaxel—prostate cancer	0.00373	0.0137	CbGbCtD
Bexarotene—CYP3A4—Doxorubicin—prostate cancer	0.00278	0.0102	CbGbCtD
Bexarotene—RXRG—prostate gland—prostate cancer	0.000813	0.242	CbGeAlD
Bexarotene—RXRA—renal system—prostate cancer	0.000631	0.188	CbGeAlD
Bexarotene—CYP2C9—urine—prostate cancer	0.000625	0.186	CbGeAlD
Bexarotene—CYP3A4—urine—prostate cancer	0.000477	0.142	CbGeAlD
Bexarotene—RXRG—testis—prostate cancer	0.000358	0.107	CbGeAlD
Bexarotene—RXRB—testis—prostate cancer	0.000337	0.1	CbGeAlD
Bexarotene—CYP3A4—renal system—prostate cancer	0.000117	0.0347	CbGeAlD
Bexarotene—Urethral disorder—Epirubicin—prostate cancer	2.43e-05	0.000144	CcSEcCtD
Bexarotene—Loss of consciousness—Prednisone—prostate cancer	2.42e-05	0.000143	CcSEcCtD
Bexarotene—Epistaxis—Doxorubicin—prostate cancer	2.41e-05	0.000142	CcSEcCtD
Bexarotene—Anorexia—Capecitabine—prostate cancer	2.41e-05	0.000142	CcSEcCtD
Bexarotene—Nausea—Estradiol—prostate cancer	2.4e-05	0.000142	CcSEcCtD
Bexarotene—Vomiting—Mitoxantrone—prostate cancer	2.4e-05	0.000142	CcSEcCtD
Bexarotene—Sinusitis—Doxorubicin—prostate cancer	2.39e-05	0.000142	CcSEcCtD
Bexarotene—Hypertension—Prednisone—prostate cancer	2.38e-05	0.000141	CcSEcCtD
Bexarotene—Rash—Mitoxantrone—prostate cancer	2.38e-05	0.000141	CcSEcCtD
Bexarotene—Dermatitis—Mitoxantrone—prostate cancer	2.38e-05	0.000141	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.38e-05	0.000141	CcSEcCtD
Bexarotene—Headache—Mitoxantrone—prostate cancer	2.36e-05	0.00014	CcSEcCtD
Bexarotene—Insomnia—Docetaxel—prostate cancer	2.36e-05	0.000139	CcSEcCtD
Bexarotene—Myalgia—Prednisone—prostate cancer	2.35e-05	0.000139	CcSEcCtD
Bexarotene—Arthralgia—Prednisone—prostate cancer	2.35e-05	0.000139	CcSEcCtD
Bexarotene—Paraesthesia—Docetaxel—prostate cancer	2.34e-05	0.000138	CcSEcCtD
Bexarotene—Anxiety—Prednisone—prostate cancer	2.34e-05	0.000138	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.33e-05	0.000138	CcSEcCtD
Bexarotene—Dyspnoea—Docetaxel—prostate cancer	2.32e-05	0.000137	CcSEcCtD
Bexarotene—Somnolence—Docetaxel—prostate cancer	2.32e-05	0.000137	CcSEcCtD
Bexarotene—Discomfort—Prednisone—prostate cancer	2.32e-05	0.000137	CcSEcCtD
Bexarotene—Eye disorder—Epirubicin—prostate cancer	2.31e-05	0.000137	CcSEcCtD
Bexarotene—Hypersensitivity—Etoposide—prostate cancer	2.31e-05	0.000137	CcSEcCtD
Bexarotene—Tinnitus—Epirubicin—prostate cancer	2.31e-05	0.000137	CcSEcCtD
Bexarotene—Haemoglobin—Doxorubicin—prostate cancer	2.3e-05	0.000136	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.3e-05	0.000136	CcSEcCtD
Bexarotene—Cardiac disorder—Epirubicin—prostate cancer	2.3e-05	0.000136	CcSEcCtD
Bexarotene—Rhinitis—Doxorubicin—prostate cancer	2.3e-05	0.000136	CcSEcCtD
Bexarotene—Dyspepsia—Docetaxel—prostate cancer	2.29e-05	0.000136	CcSEcCtD
Bexarotene—Haemorrhage—Doxorubicin—prostate cancer	2.29e-05	0.000135	CcSEcCtD
Bexarotene—Insomnia—Capecitabine—prostate cancer	2.28e-05	0.000135	CcSEcCtD
Bexarotene—Hypoaesthesia—Doxorubicin—prostate cancer	2.28e-05	0.000135	CcSEcCtD
Bexarotene—Pharyngitis—Doxorubicin—prostate cancer	2.27e-05	0.000134	CcSEcCtD
Bexarotene—Paraesthesia—Capecitabine—prostate cancer	2.27e-05	0.000134	CcSEcCtD
Bexarotene—Decreased appetite—Docetaxel—prostate cancer	2.27e-05	0.000134	CcSEcCtD
Bexarotene—Urinary tract disorder—Doxorubicin—prostate cancer	2.26e-05	0.000134	CcSEcCtD
Bexarotene—Oedema peripheral—Doxorubicin—prostate cancer	2.26e-05	0.000133	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Docetaxel—prostate cancer	2.25e-05	0.000133	CcSEcCtD
Bexarotene—Asthenia—Etoposide—prostate cancer	2.25e-05	0.000133	CcSEcCtD
Bexarotene—Connective tissue disorder—Doxorubicin—prostate cancer	2.25e-05	0.000133	CcSEcCtD
Bexarotene—Dyspnoea—Capecitabine—prostate cancer	2.25e-05	0.000133	CcSEcCtD
Bexarotene—Oedema—Prednisone—prostate cancer	2.25e-05	0.000133	CcSEcCtD
Bexarotene—Fatigue—Docetaxel—prostate cancer	2.25e-05	0.000133	CcSEcCtD
Bexarotene—Angiopathy—Epirubicin—prostate cancer	2.25e-05	0.000133	CcSEcCtD
Bexarotene—Urethral disorder—Doxorubicin—prostate cancer	2.25e-05	0.000133	CcSEcCtD
Bexarotene—Nausea—Mitoxantrone—prostate cancer	2.24e-05	0.000133	CcSEcCtD
Bexarotene—Infection—Prednisone—prostate cancer	2.23e-05	0.000132	CcSEcCtD
Bexarotene—Constipation—Docetaxel—prostate cancer	2.23e-05	0.000132	CcSEcCtD
Bexarotene—Pain—Docetaxel—prostate cancer	2.23e-05	0.000132	CcSEcCtD
Bexarotene—Dyspepsia—Capecitabine—prostate cancer	2.22e-05	0.000131	CcSEcCtD
Bexarotene—Chills—Epirubicin—prostate cancer	2.22e-05	0.000131	CcSEcCtD
Bexarotene—Pruritus—Etoposide—prostate cancer	2.22e-05	0.000131	CcSEcCtD
Bexarotene—Shock—Prednisone—prostate cancer	2.21e-05	0.000131	CcSEcCtD
Bexarotene—Arrhythmia—Epirubicin—prostate cancer	2.21e-05	0.000131	CcSEcCtD
Bexarotene—Nervous system disorder—Prednisone—prostate cancer	2.21e-05	0.00013	CcSEcCtD
Bexarotene—Tachycardia—Prednisone—prostate cancer	2.19e-05	0.00013	CcSEcCtD
Bexarotene—Decreased appetite—Capecitabine—prostate cancer	2.19e-05	0.00013	CcSEcCtD
Bexarotene—Alopecia—Epirubicin—prostate cancer	2.19e-05	0.000129	CcSEcCtD
Bexarotene—Skin disorder—Prednisone—prostate cancer	2.18e-05	0.000129	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Capecitabine—prostate cancer	2.18e-05	0.000129	CcSEcCtD
Bexarotene—Fatigue—Capecitabine—prostate cancer	2.18e-05	0.000129	CcSEcCtD
Bexarotene—Hyperhidrosis—Prednisone—prostate cancer	2.17e-05	0.000129	CcSEcCtD
Bexarotene—Pain—Capecitabine—prostate cancer	2.16e-05	0.000128	CcSEcCtD
Bexarotene—Constipation—Capecitabine—prostate cancer	2.16e-05	0.000128	CcSEcCtD
Bexarotene—Erythema—Epirubicin—prostate cancer	2.15e-05	0.000127	CcSEcCtD
Bexarotene—Malnutrition—Epirubicin—prostate cancer	2.15e-05	0.000127	CcSEcCtD
Bexarotene—Feeling abnormal—Docetaxel—prostate cancer	2.15e-05	0.000127	CcSEcCtD
Bexarotene—Diarrhoea—Etoposide—prostate cancer	2.15e-05	0.000127	CcSEcCtD
Bexarotene—Anorexia—Prednisone—prostate cancer	2.14e-05	0.000127	CcSEcCtD
Bexarotene—Eye disorder—Doxorubicin—prostate cancer	2.14e-05	0.000127	CcSEcCtD
Bexarotene—Tinnitus—Doxorubicin—prostate cancer	2.14e-05	0.000126	CcSEcCtD
Bexarotene—Gastrointestinal pain—Docetaxel—prostate cancer	2.13e-05	0.000126	CcSEcCtD
Bexarotene—Cardiac disorder—Doxorubicin—prostate cancer	2.13e-05	0.000126	CcSEcCtD
Bexarotene—Flatulence—Epirubicin—prostate cancer	2.12e-05	0.000126	CcSEcCtD
Bexarotene—Tension—Epirubicin—prostate cancer	2.11e-05	0.000125	CcSEcCtD
Bexarotene—Dysgeusia—Epirubicin—prostate cancer	2.11e-05	0.000125	CcSEcCtD
Bexarotene—Nervousness—Epirubicin—prostate cancer	2.09e-05	0.000124	CcSEcCtD
Bexarotene—Back pain—Epirubicin—prostate cancer	2.08e-05	0.000123	CcSEcCtD
Bexarotene—Feeling abnormal—Capecitabine—prostate cancer	2.08e-05	0.000123	CcSEcCtD
Bexarotene—Angiopathy—Doxorubicin—prostate cancer	2.08e-05	0.000123	CcSEcCtD
Bexarotene—Dizziness—Etoposide—prostate cancer	2.07e-05	0.000123	CcSEcCtD
Bexarotene—Muscle spasms—Epirubicin—prostate cancer	2.07e-05	0.000123	CcSEcCtD
Bexarotene—Gastrointestinal pain—Capecitabine—prostate cancer	2.06e-05	0.000122	CcSEcCtD
Bexarotene—Abdominal pain—Docetaxel—prostate cancer	2.06e-05	0.000122	CcSEcCtD
Bexarotene—Body temperature increased—Docetaxel—prostate cancer	2.06e-05	0.000122	CcSEcCtD
Bexarotene—Chills—Doxorubicin—prostate cancer	2.05e-05	0.000122	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Prednisone—prostate cancer	2.05e-05	0.000121	CcSEcCtD
Bexarotene—Arrhythmia—Doxorubicin—prostate cancer	2.05e-05	0.000121	CcSEcCtD
Bexarotene—Insomnia—Prednisone—prostate cancer	2.03e-05	0.00012	CcSEcCtD
Bexarotene—Alopecia—Doxorubicin—prostate cancer	2.02e-05	0.00012	CcSEcCtD
Bexarotene—Paraesthesia—Prednisone—prostate cancer	2.02e-05	0.000119	CcSEcCtD
Bexarotene—Ill-defined disorder—Epirubicin—prostate cancer	2e-05	0.000118	CcSEcCtD
Bexarotene—Body temperature increased—Capecitabine—prostate cancer	2e-05	0.000118	CcSEcCtD
Bexarotene—Abdominal pain—Capecitabine—prostate cancer	2e-05	0.000118	CcSEcCtD
Bexarotene—Vomiting—Etoposide—prostate cancer	1.99e-05	0.000118	CcSEcCtD
Bexarotene—Malnutrition—Doxorubicin—prostate cancer	1.99e-05	0.000118	CcSEcCtD
Bexarotene—Erythema—Doxorubicin—prostate cancer	1.99e-05	0.000118	CcSEcCtD
Bexarotene—Anaemia—Epirubicin—prostate cancer	1.99e-05	0.000118	CcSEcCtD
Bexarotene—Agitation—Epirubicin—prostate cancer	1.98e-05	0.000117	CcSEcCtD
Bexarotene—Dyspepsia—Prednisone—prostate cancer	1.98e-05	0.000117	CcSEcCtD
Bexarotene—Rash—Etoposide—prostate cancer	1.98e-05	0.000117	CcSEcCtD
Bexarotene—Dermatitis—Etoposide—prostate cancer	1.98e-05	0.000117	CcSEcCtD
Bexarotene—Headache—Etoposide—prostate cancer	1.97e-05	0.000116	CcSEcCtD
Bexarotene—Flatulence—Doxorubicin—prostate cancer	1.96e-05	0.000116	CcSEcCtD
Bexarotene—Tension—Doxorubicin—prostate cancer	1.96e-05	0.000116	CcSEcCtD
Bexarotene—Decreased appetite—Prednisone—prostate cancer	1.95e-05	0.000116	CcSEcCtD
Bexarotene—Dysgeusia—Doxorubicin—prostate cancer	1.95e-05	0.000115	CcSEcCtD
Bexarotene—Malaise—Epirubicin—prostate cancer	1.94e-05	0.000115	CcSEcCtD
Bexarotene—Fatigue—Prednisone—prostate cancer	1.94e-05	0.000115	CcSEcCtD
Bexarotene—Nervousness—Doxorubicin—prostate cancer	1.94e-05	0.000115	CcSEcCtD
Bexarotene—Vertigo—Epirubicin—prostate cancer	1.94e-05	0.000115	CcSEcCtD
Bexarotene—Syncope—Epirubicin—prostate cancer	1.93e-05	0.000114	CcSEcCtD
Bexarotene—Leukopenia—Epirubicin—prostate cancer	1.93e-05	0.000114	CcSEcCtD
Bexarotene—Back pain—Doxorubicin—prostate cancer	1.93e-05	0.000114	CcSEcCtD
Bexarotene—Constipation—Prednisone—prostate cancer	1.92e-05	0.000114	CcSEcCtD
Bexarotene—Hypersensitivity—Docetaxel—prostate cancer	1.92e-05	0.000114	CcSEcCtD
Bexarotene—Muscle spasms—Doxorubicin—prostate cancer	1.92e-05	0.000113	CcSEcCtD
Bexarotene—Palpitations—Epirubicin—prostate cancer	1.9e-05	0.000113	CcSEcCtD
Bexarotene—Loss of consciousness—Epirubicin—prostate cancer	1.89e-05	0.000112	CcSEcCtD
Bexarotene—Cough—Epirubicin—prostate cancer	1.88e-05	0.000111	CcSEcCtD
Bexarotene—Asthenia—Docetaxel—prostate cancer	1.87e-05	0.000111	CcSEcCtD
Bexarotene—Nausea—Etoposide—prostate cancer	1.86e-05	0.00011	CcSEcCtD
Bexarotene—Hypertension—Epirubicin—prostate cancer	1.86e-05	0.00011	CcSEcCtD
Bexarotene—Hypersensitivity—Capecitabine—prostate cancer	1.86e-05	0.00011	CcSEcCtD
Bexarotene—Feeling abnormal—Prednisone—prostate cancer	1.85e-05	0.00011	CcSEcCtD
Bexarotene—Ill-defined disorder—Doxorubicin—prostate cancer	1.85e-05	0.000109	CcSEcCtD
Bexarotene—Pruritus—Docetaxel—prostate cancer	1.84e-05	0.000109	CcSEcCtD
Bexarotene—Anaemia—Doxorubicin—prostate cancer	1.84e-05	0.000109	CcSEcCtD
Bexarotene—Gastrointestinal pain—Prednisone—prostate cancer	1.84e-05	0.000109	CcSEcCtD
Bexarotene—Chest pain—Epirubicin—prostate cancer	1.83e-05	0.000109	CcSEcCtD
Bexarotene—Arthralgia—Epirubicin—prostate cancer	1.83e-05	0.000109	CcSEcCtD
Bexarotene—Myalgia—Epirubicin—prostate cancer	1.83e-05	0.000109	CcSEcCtD
Bexarotene—Agitation—Doxorubicin—prostate cancer	1.83e-05	0.000108	CcSEcCtD
Bexarotene—Anxiety—Epirubicin—prostate cancer	1.83e-05	0.000108	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	1.82e-05	0.000108	CcSEcCtD
Bexarotene—Discomfort—Epirubicin—prostate cancer	1.81e-05	0.000107	CcSEcCtD
Bexarotene—Asthenia—Capecitabine—prostate cancer	1.81e-05	0.000107	CcSEcCtD
Bexarotene—Malaise—Doxorubicin—prostate cancer	1.8e-05	0.000106	CcSEcCtD
Bexarotene—Dry mouth—Epirubicin—prostate cancer	1.79e-05	0.000106	CcSEcCtD
Bexarotene—Vertigo—Doxorubicin—prostate cancer	1.79e-05	0.000106	CcSEcCtD
Bexarotene—Syncope—Doxorubicin—prostate cancer	1.79e-05	0.000106	CcSEcCtD
Bexarotene—Pruritus—Capecitabine—prostate cancer	1.79e-05	0.000106	CcSEcCtD
Bexarotene—Leukopenia—Doxorubicin—prostate cancer	1.78e-05	0.000106	CcSEcCtD
Bexarotene—Diarrhoea—Docetaxel—prostate cancer	1.78e-05	0.000106	CcSEcCtD
Bexarotene—Abdominal pain—Prednisone—prostate cancer	1.78e-05	0.000105	CcSEcCtD
Bexarotene—Body temperature increased—Prednisone—prostate cancer	1.78e-05	0.000105	CcSEcCtD
Bexarotene—Confusional state—Epirubicin—prostate cancer	1.77e-05	0.000105	CcSEcCtD
Bexarotene—Palpitations—Doxorubicin—prostate cancer	1.76e-05	0.000104	CcSEcCtD
Bexarotene—Oedema—Epirubicin—prostate cancer	1.76e-05	0.000104	CcSEcCtD
Bexarotene—Loss of consciousness—Doxorubicin—prostate cancer	1.75e-05	0.000104	CcSEcCtD
Bexarotene—Infection—Epirubicin—prostate cancer	1.75e-05	0.000103	CcSEcCtD
Bexarotene—Cough—Doxorubicin—prostate cancer	1.74e-05	0.000103	CcSEcCtD
Bexarotene—Shock—Epirubicin—prostate cancer	1.73e-05	0.000102	CcSEcCtD
Bexarotene—Diarrhoea—Capecitabine—prostate cancer	1.73e-05	0.000102	CcSEcCtD
Bexarotene—Nervous system disorder—Epirubicin—prostate cancer	1.72e-05	0.000102	CcSEcCtD
Bexarotene—Dizziness—Docetaxel—prostate cancer	1.72e-05	0.000102	CcSEcCtD
Bexarotene—Thrombocytopenia—Epirubicin—prostate cancer	1.72e-05	0.000102	CcSEcCtD
Bexarotene—Hypertension—Doxorubicin—prostate cancer	1.72e-05	0.000102	CcSEcCtD
Bexarotene—Tachycardia—Epirubicin—prostate cancer	1.72e-05	0.000102	CcSEcCtD
Bexarotene—Skin disorder—Epirubicin—prostate cancer	1.71e-05	0.000101	CcSEcCtD
Bexarotene—Hyperhidrosis—Epirubicin—prostate cancer	1.7e-05	0.000101	CcSEcCtD
Bexarotene—Myalgia—Doxorubicin—prostate cancer	1.7e-05	0.0001	CcSEcCtD
Bexarotene—Arthralgia—Doxorubicin—prostate cancer	1.7e-05	0.0001	CcSEcCtD
Bexarotene—Chest pain—Doxorubicin—prostate cancer	1.7e-05	0.0001	CcSEcCtD
Bexarotene—Anxiety—Doxorubicin—prostate cancer	1.69e-05	0.0001	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.69e-05	9.97e-05	CcSEcCtD
Bexarotene—Discomfort—Doxorubicin—prostate cancer	1.68e-05	9.92e-05	CcSEcCtD
Bexarotene—Anorexia—Epirubicin—prostate cancer	1.68e-05	9.92e-05	CcSEcCtD
Bexarotene—Dizziness—Capecitabine—prostate cancer	1.67e-05	9.87e-05	CcSEcCtD
Bexarotene—Dry mouth—Doxorubicin—prostate cancer	1.66e-05	9.82e-05	CcSEcCtD
Bexarotene—Vomiting—Docetaxel—prostate cancer	1.66e-05	9.81e-05	CcSEcCtD
Bexarotene—Hypersensitivity—Prednisone—prostate cancer	1.66e-05	9.8e-05	CcSEcCtD
Bexarotene—Rash—Docetaxel—prostate cancer	1.64e-05	9.72e-05	CcSEcCtD
Bexarotene—Dermatitis—Docetaxel—prostate cancer	1.64e-05	9.72e-05	CcSEcCtD
Bexarotene—Confusional state—Doxorubicin—prostate cancer	1.64e-05	9.71e-05	CcSEcCtD
Bexarotene—Headache—Docetaxel—prostate cancer	1.63e-05	9.66e-05	CcSEcCtD
Bexarotene—Oedema—Doxorubicin—prostate cancer	1.63e-05	9.63e-05	CcSEcCtD
Bexarotene—Infection—Doxorubicin—prostate cancer	1.62e-05	9.56e-05	CcSEcCtD
Bexarotene—Asthenia—Prednisone—prostate cancer	1.61e-05	9.54e-05	CcSEcCtD
Bexarotene—Vomiting—Capecitabine—prostate cancer	1.6e-05	9.49e-05	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.6e-05	9.48e-05	CcSEcCtD
Bexarotene—Shock—Doxorubicin—prostate cancer	1.6e-05	9.47e-05	CcSEcCtD
Bexarotene—Nervous system disorder—Doxorubicin—prostate cancer	1.6e-05	9.44e-05	CcSEcCtD
Bexarotene—Thrombocytopenia—Doxorubicin—prostate cancer	1.59e-05	9.42e-05	CcSEcCtD
Bexarotene—Rash—Capecitabine—prostate cancer	1.59e-05	9.41e-05	CcSEcCtD
Bexarotene—Pruritus—Prednisone—prostate cancer	1.59e-05	9.41e-05	CcSEcCtD
Bexarotene—Insomnia—Epirubicin—prostate cancer	1.59e-05	9.41e-05	CcSEcCtD
Bexarotene—Dermatitis—Capecitabine—prostate cancer	1.59e-05	9.41e-05	CcSEcCtD
Bexarotene—Tachycardia—Doxorubicin—prostate cancer	1.59e-05	9.39e-05	CcSEcCtD
Bexarotene—Headache—Capecitabine—prostate cancer	1.58e-05	9.35e-05	CcSEcCtD
Bexarotene—Skin disorder—Doxorubicin—prostate cancer	1.58e-05	9.35e-05	CcSEcCtD
Bexarotene—Paraesthesia—Epirubicin—prostate cancer	1.58e-05	9.34e-05	CcSEcCtD
Bexarotene—Hyperhidrosis—Doxorubicin—prostate cancer	1.57e-05	9.3e-05	CcSEcCtD
Bexarotene—Dyspnoea—Epirubicin—prostate cancer	1.57e-05	9.27e-05	CcSEcCtD
Bexarotene—Somnolence—Epirubicin—prostate cancer	1.56e-05	9.25e-05	CcSEcCtD
Bexarotene—Anorexia—Doxorubicin—prostate cancer	1.55e-05	9.17e-05	CcSEcCtD
Bexarotene—Nausea—Docetaxel—prostate cancer	1.55e-05	9.16e-05	CcSEcCtD
Bexarotene—Dyspepsia—Epirubicin—prostate cancer	1.55e-05	9.16e-05	CcSEcCtD
Bexarotene—Diarrhoea—Prednisone—prostate cancer	1.54e-05	9.1e-05	CcSEcCtD
Bexarotene—Decreased appetite—Epirubicin—prostate cancer	1.53e-05	9.04e-05	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Epirubicin—prostate cancer	1.52e-05	8.98e-05	CcSEcCtD
Bexarotene—Fatigue—Epirubicin—prostate cancer	1.52e-05	8.97e-05	CcSEcCtD
Bexarotene—Constipation—Epirubicin—prostate cancer	1.5e-05	8.9e-05	CcSEcCtD
Bexarotene—Pain—Epirubicin—prostate cancer	1.5e-05	8.9e-05	CcSEcCtD
Bexarotene—Nausea—Capecitabine—prostate cancer	1.5e-05	8.87e-05	CcSEcCtD
Bexarotene—Dizziness—Prednisone—prostate cancer	1.49e-05	8.8e-05	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.48e-05	8.77e-05	CcSEcCtD
Bexarotene—Insomnia—Doxorubicin—prostate cancer	1.47e-05	8.71e-05	CcSEcCtD
Bexarotene—Paraesthesia—Doxorubicin—prostate cancer	1.46e-05	8.64e-05	CcSEcCtD
Bexarotene—Dyspnoea—Doxorubicin—prostate cancer	1.45e-05	8.58e-05	CcSEcCtD
Bexarotene—Feeling abnormal—Epirubicin—prostate cancer	1.45e-05	8.57e-05	CcSEcCtD
Bexarotene—Somnolence—Doxorubicin—prostate cancer	1.45e-05	8.56e-05	CcSEcCtD
Bexarotene—Gastrointestinal pain—Epirubicin—prostate cancer	1.44e-05	8.51e-05	CcSEcCtD
Bexarotene—Dyspepsia—Doxorubicin—prostate cancer	1.43e-05	8.47e-05	CcSEcCtD
Bexarotene—Vomiting—Prednisone—prostate cancer	1.43e-05	8.46e-05	CcSEcCtD
Bexarotene—Rash—Prednisone—prostate cancer	1.42e-05	8.39e-05	CcSEcCtD
Bexarotene—Dermatitis—Prednisone—prostate cancer	1.42e-05	8.38e-05	CcSEcCtD
Bexarotene—Decreased appetite—Doxorubicin—prostate cancer	1.41e-05	8.37e-05	CcSEcCtD
Bexarotene—Headache—Prednisone—prostate cancer	1.41e-05	8.33e-05	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.4e-05	8.31e-05	CcSEcCtD
Bexarotene—Fatigue—Doxorubicin—prostate cancer	1.4e-05	8.3e-05	CcSEcCtD
Bexarotene—Pain—Doxorubicin—prostate cancer	1.39e-05	8.23e-05	CcSEcCtD
Bexarotene—Constipation—Doxorubicin—prostate cancer	1.39e-05	8.23e-05	CcSEcCtD
Bexarotene—Abdominal pain—Epirubicin—prostate cancer	1.39e-05	8.22e-05	CcSEcCtD
Bexarotene—Body temperature increased—Epirubicin—prostate cancer	1.39e-05	8.22e-05	CcSEcCtD
Bexarotene—Feeling abnormal—Doxorubicin—prostate cancer	1.34e-05	7.93e-05	CcSEcCtD
Bexarotene—Nausea—Prednisone—prostate cancer	1.34e-05	7.9e-05	CcSEcCtD
Bexarotene—Gastrointestinal pain—Doxorubicin—prostate cancer	1.33e-05	7.87e-05	CcSEcCtD
Bexarotene—Hypersensitivity—Epirubicin—prostate cancer	1.3e-05	7.66e-05	CcSEcCtD
Bexarotene—Abdominal pain—Doxorubicin—prostate cancer	1.29e-05	7.61e-05	CcSEcCtD
Bexarotene—Body temperature increased—Doxorubicin—prostate cancer	1.29e-05	7.61e-05	CcSEcCtD
Bexarotene—Asthenia—Epirubicin—prostate cancer	1.26e-05	7.46e-05	CcSEcCtD
Bexarotene—Pruritus—Epirubicin—prostate cancer	1.24e-05	7.36e-05	CcSEcCtD
Bexarotene—Diarrhoea—Epirubicin—prostate cancer	1.2e-05	7.12e-05	CcSEcCtD
Bexarotene—Hypersensitivity—Doxorubicin—prostate cancer	1.2e-05	7.09e-05	CcSEcCtD
Bexarotene—Asthenia—Doxorubicin—prostate cancer	1.17e-05	6.91e-05	CcSEcCtD
Bexarotene—Dizziness—Epirubicin—prostate cancer	1.16e-05	6.88e-05	CcSEcCtD
Bexarotene—Pruritus—Doxorubicin—prostate cancer	1.15e-05	6.81e-05	CcSEcCtD
Bexarotene—Vomiting—Epirubicin—prostate cancer	1.12e-05	6.61e-05	CcSEcCtD
Bexarotene—Diarrhoea—Doxorubicin—prostate cancer	1.11e-05	6.59e-05	CcSEcCtD
Bexarotene—Rash—Epirubicin—prostate cancer	1.11e-05	6.56e-05	CcSEcCtD
Bexarotene—Dermatitis—Epirubicin—prostate cancer	1.11e-05	6.55e-05	CcSEcCtD
Bexarotene—Headache—Epirubicin—prostate cancer	1.1e-05	6.52e-05	CcSEcCtD
Bexarotene—Dizziness—Doxorubicin—prostate cancer	1.08e-05	6.36e-05	CcSEcCtD
Bexarotene—Nausea—Epirubicin—prostate cancer	1.04e-05	6.18e-05	CcSEcCtD
Bexarotene—Vomiting—Doxorubicin—prostate cancer	1.03e-05	6.12e-05	CcSEcCtD
Bexarotene—Rash—Doxorubicin—prostate cancer	1.03e-05	6.07e-05	CcSEcCtD
Bexarotene—Dermatitis—Doxorubicin—prostate cancer	1.02e-05	6.06e-05	CcSEcCtD
Bexarotene—Headache—Doxorubicin—prostate cancer	1.02e-05	6.03e-05	CcSEcCtD
Bexarotene—Nausea—Doxorubicin—prostate cancer	9.66e-06	5.72e-05	CcSEcCtD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	7.02e-06	6.24e-05	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MMP9—prostate cancer	7.01e-06	6.23e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GGT1—prostate cancer	6.83e-06	6.07e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—ERCC2—prostate cancer	6.81e-06	6.06e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—NCOA1—prostate cancer	6.72e-06	5.98e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—NR3C1—prostate cancer	6.7e-06	5.96e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	6.69e-06	5.95e-05	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—EP300—prostate cancer	6.64e-06	5.91e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP19A1—prostate cancer	6.63e-06	5.89e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—B4GALT4—prostate cancer	6.61e-06	5.88e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HPGD—prostate cancer	6.61e-06	5.88e-05	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—SRC—prostate cancer	6.46e-06	5.74e-05	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—VEGFA—prostate cancer	6.29e-06	5.59e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PPARA—prostate cancer	6.28e-06	5.59e-05	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—STAT3—prostate cancer	6.23e-06	5.54e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	6.22e-06	5.53e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—TNFRSF21—prostate cancer	6.21e-06	5.53e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GRHL1—prostate cancer	6.19e-06	5.5e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PSAT1—prostate cancer	6.19e-06	5.5e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CSAD—prostate cancer	6.19e-06	5.5e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CBR1—prostate cancer	6.19e-06	5.5e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ADI1—prostate cancer	6.19e-06	5.5e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—TST—prostate cancer	6.19e-06	5.5e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—COMT—prostate cancer	6.16e-06	5.48e-05	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—MYC—prostate cancer	6.15e-06	5.47e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTP1—prostate cancer	6.13e-06	5.45e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—MTAP—prostate cancer	6.05e-06	5.37e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP7B1—prostate cancer	6.05e-06	5.37e-05	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—MYC—prostate cancer	6.04e-06	5.37e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ITPR1—prostate cancer	6.03e-06	5.36e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.93e-06	5.27e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	5.91e-06	5.25e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SULT1E1—prostate cancer	5.89e-06	5.24e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SRD5A1—prostate cancer	5.89e-06	5.24e-05	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TGFB1—prostate cancer	5.77e-06	5.13e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—UGT2B15—prostate cancer	5.75e-06	5.11e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—UGT2B17—prostate cancer	5.75e-06	5.11e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GRHPR—prostate cancer	5.75e-06	5.11e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CKMT2—prostate cancer	5.75e-06	5.11e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	5.72e-06	5.09e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—TYMS—prostate cancer	5.7e-06	5.07e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—ESR1—prostate cancer	5.69e-06	5.06e-05	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—MYC—prostate cancer	5.68e-06	5.05e-05	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—EGFR—prostate cancer	5.66e-06	5.03e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	5.64e-06	5.01e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTM1—prostate cancer	5.63e-06	5.01e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HSD17B3—prostate cancer	5.62e-06	5e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ACSL4—prostate cancer	5.62e-06	5e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	5.56e-06	4.94e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—LPL—prostate cancer	5.53e-06	4.92e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AOX1—prostate cancer	5.41e-06	4.81e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PGAM2—prostate cancer	5.41e-06	4.81e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—RFK—prostate cancer	5.41e-06	4.81e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—MBTPS1—prostate cancer	5.41e-06	4.81e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NAGLU—prostate cancer	5.41e-06	4.81e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SULT2B1—prostate cancer	5.41e-06	4.81e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTM3—prostate cancer	5.41e-06	4.81e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—UMPS—prostate cancer	5.39e-06	4.79e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PHGDH—prostate cancer	5.39e-06	4.79e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ARG2—prostate cancer	5.39e-06	4.79e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	5.36e-06	4.77e-05	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—KRAS—prostate cancer	5.35e-06	4.76e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP1A1—prostate cancer	5.34e-06	4.75e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ERCC2—prostate cancer	5.3e-06	4.71e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LDHB—prostate cancer	5.28e-06	4.7e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP3A5—prostate cancer	5.19e-06	4.61e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP3A43—prostate cancer	5.13e-06	4.56e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AMACR—prostate cancer	5.13e-06	4.56e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NAT1—prostate cancer	5.13e-06	4.56e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—DEGS1—prostate cancer	5.13e-06	4.56e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SRD5A2—prostate cancer	5.13e-06	4.56e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—UCP3—prostate cancer	5.01e-06	4.45e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PDHA1—prostate cancer	5.01e-06	4.45e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTA3—prostate cancer	5.01e-06	4.45e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—TCN2—prostate cancer	5.01e-06	4.45e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—CREBBP—prostate cancer	4.99e-06	4.44e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—MTHFR—prostate cancer	4.98e-06	4.43e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HSD17B1—prostate cancer	4.89e-06	4.35e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPARA—prostate cancer	4.89e-06	4.34e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HSD3B1—prostate cancer	4.78e-06	4.25e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC22A3—prostate cancer	4.78e-06	4.25e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—SERPINE1—prostate cancer	4.68e-06	4.16e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—LPL—prostate cancer	4.64e-06	4.12e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CAV1—prostate cancer	4.59e-06	4.08e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—TBXAS1—prostate cancer	4.58e-06	4.07e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTA4—prostate cancer	4.58e-06	4.07e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	4.48e-06	3.98e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTA2—prostate cancer	4.46e-06	3.97e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SULT1A1—prostate cancer	4.41e-06	3.92e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ABCG5—prostate cancer	4.41e-06	3.92e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.39e-06	3.9e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—B4GALT4—prostate cancer	4.36e-06	3.88e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HPGD—prostate cancer	4.36e-06	3.88e-05	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—IL6—prostate cancer	4.35e-06	3.87e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTA1—prostate cancer	4.31e-06	3.83e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HSD3B2—prostate cancer	4.26e-06	3.79e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTO1—prostate cancer	4.26e-06	3.79e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NAT2—prostate cancer	4.26e-06	3.79e-05	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—AKT1—prostate cancer	4.19e-06	3.73e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3CG—prostate cancer	4.18e-06	3.72e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—TNFRSF21—prostate cancer	4.1e-06	3.64e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	4.1e-06	3.64e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PLCB2—prostate cancer	4.08e-06	3.63e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LRP2—prostate cancer	4.08e-06	3.63e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP2C18—prostate cancer	4.08e-06	3.63e-05	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—AKT1—prostate cancer	4.01e-06	3.57e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—P4HB—prostate cancer	4e-06	3.56e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP7B1—prostate cancer	3.99e-06	3.54e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—MTAP—prostate cancer	3.99e-06	3.54e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—INS—prostate cancer	3.96e-06	3.52e-05	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—AKT1—prostate cancer	3.94e-06	3.5e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC22A1—prostate cancer	3.9e-06	3.46e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SULT1E1—prostate cancer	3.89e-06	3.45e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SRD5A1—prostate cancer	3.89e-06	3.45e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CREBBP—prostate cancer	3.88e-06	3.45e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	3.85e-06	3.42e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SULT2A1—prostate cancer	3.8e-06	3.38e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—MED12—prostate cancer	3.73e-06	3.32e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HSD17B3—prostate cancer	3.71e-06	3.3e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ACSL4—prostate cancer	3.71e-06	3.3e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GNG5—prostate cancer	3.71e-06	3.29e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3CD—prostate cancer	3.68e-06	3.27e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NCOA3—prostate cancer	3.57e-06	3.17e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PHGDH—prostate cancer	3.55e-06	3.16e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—UMPS—prostate cancer	3.55e-06	3.16e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ARG2—prostate cancer	3.55e-06	3.16e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.51e-06	3.12e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LDHB—prostate cancer	3.48e-06	3.1e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—NOS3—prostate cancer	3.47e-06	3.09e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP3A5—prostate cancer	3.42e-06	3.04e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HPGDS—prostate cancer	3.4e-06	3.03e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP2C19—prostate cancer	3.38e-06	3.01e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PDHA1—prostate cancer	3.3e-06	2.94e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—TCN2—prostate cancer	3.3e-06	2.94e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—UCP3—prostate cancer	3.3e-06	2.94e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTA3—prostate cancer	3.3e-06	2.94e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTT1—prostate cancer	3.3e-06	2.94e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ACHE—prostate cancer	3.3e-06	2.94e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP2A6—prostate cancer	3.26e-06	2.9e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.25e-06	2.89e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3CB—prostate cancer	3.21e-06	2.85e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTGS2—prostate cancer	3.18e-06	2.82e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AKR1C3—prostate cancer	3.18e-06	2.82e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PRKACB—prostate cancer	3.16e-06	2.81e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC22A3—prostate cancer	3.15e-06	2.8e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HSD3B1—prostate cancer	3.15e-06	2.8e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP17A1—prostate cancer	3.13e-06	2.78e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.08e-06	2.74e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTA4—prostate cancer	3.02e-06	2.69e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—TBXAS1—prostate cancer	3.02e-06	2.69e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NCOA2—prostate cancer	2.98e-06	2.65e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—MYC—prostate cancer	2.96e-06	2.63e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTA2—prostate cancer	2.94e-06	2.62e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ABCG5—prostate cancer	2.91e-06	2.59e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.91e-06	2.59e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC5A5—prostate cancer	2.84e-06	2.53e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTA1—prostate cancer	2.84e-06	2.53e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.81e-06	2.5e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTO1—prostate cancer	2.81e-06	2.5e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NAT2—prostate cancer	2.81e-06	2.5e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP2E1—prostate cancer	2.78e-06	2.47e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTEN—prostate cancer	2.77e-06	2.46e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NQO1—prostate cancer	2.74e-06	2.44e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—TH—prostate cancer	2.7e-06	2.41e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PLCB2—prostate cancer	2.69e-06	2.39e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.69e-06	2.39e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LRP2—prostate cancer	2.69e-06	2.39e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.69e-06	2.39e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP3A4—prostate cancer	2.68e-06	2.38e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.66e-06	2.37e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—EP300—prostate cancer	2.64e-06	2.35e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—P4HB—prostate cancer	2.64e-06	2.35e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP1B1—prostate cancer	2.63e-06	2.34e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.57e-06	2.28e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GGT1—prostate cancer	2.55e-06	2.27e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NCOA1—prostate cancer	2.51e-06	2.23e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.5e-06	2.23e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP19A1—prostate cancer	2.47e-06	2.2e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—MED12—prostate cancer	2.46e-06	2.19e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GNG5—prostate cancer	2.44e-06	2.17e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—RXRA—prostate cancer	2.39e-06	2.12e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NCOA3—prostate cancer	2.35e-06	2.09e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.32e-06	2.06e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—COMT—prostate cancer	2.3e-06	2.04e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTP1—prostate cancer	2.29e-06	2.04e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ITPR1—prostate cancer	2.25e-06	2e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HPGDS—prostate cancer	2.25e-06	2e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.23e-06	1.98e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.21e-06	1.97e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTT1—prostate cancer	2.18e-06	1.94e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ACHE—prostate cancer	2.18e-06	1.94e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.15e-06	1.91e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—TYMS—prostate cancer	2.13e-06	1.89e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTM1—prostate cancer	2.1e-06	1.87e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.09e-06	1.86e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PRKACB—prostate cancer	2.08e-06	1.85e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LPL—prostate cancer	2.06e-06	1.84e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.06e-06	1.83e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—AKT1—prostate cancer	2.05e-06	1.83e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.99e-06	1.77e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ERCC2—prostate cancer	1.98e-06	1.76e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NCOA2—prostate cancer	1.96e-06	1.75e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3CA—prostate cancer	1.95e-06	1.74e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.87e-06	1.67e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—MTHFR—prostate cancer	1.86e-06	1.65e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.83e-06	1.63e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPARA—prostate cancer	1.82e-06	1.62e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NQO1—prostate cancer	1.81e-06	1.61e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—TH—prostate cancer	1.78e-06	1.59e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.74e-06	1.54e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CAV1—prostate cancer	1.71e-06	1.52e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GGT1—prostate cancer	1.68e-06	1.49e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NCOA1—prostate cancer	1.66e-06	1.47e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.64e-06	1.46e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.63e-06	1.45e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—AKT1—prostate cancer	1.6e-06	1.42e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—RXRA—prostate cancer	1.57e-06	1.4e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.56e-06	1.39e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—COMT—prostate cancer	1.52e-06	1.35e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTP1—prostate cancer	1.51e-06	1.34e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ITPR1—prostate cancer	1.49e-06	1.32e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—INS—prostate cancer	1.48e-06	1.31e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CREBBP—prostate cancer	1.45e-06	1.29e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—TYMS—prostate cancer	1.4e-06	1.25e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTM1—prostate cancer	1.39e-06	1.23e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.37e-06	1.22e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LPL—prostate cancer	1.36e-06	1.21e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.32e-06	1.17e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ERCC2—prostate cancer	1.3e-06	1.16e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NOS3—prostate cancer	1.3e-06	1.15e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—MTHFR—prostate cancer	1.23e-06	1.09e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPARA—prostate cancer	1.2e-06	1.07e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.2e-06	1.06e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTGS2—prostate cancer	1.19e-06	1.05e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CAV1—prostate cancer	1.13e-06	1.01e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTEN—prostate cancer	1.03e-06	9.2e-06	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.03e-06	9.16e-06	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—EP300—prostate cancer	9.86e-07	8.77e-06	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—INS—prostate cancer	9.75e-07	8.67e-06	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CREBBP—prostate cancer	9.55e-07	8.49e-06	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3CD—prostate cancer	9.06e-07	8.05e-06	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NOS3—prostate cancer	8.55e-07	7.6e-06	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3CB—prostate cancer	7.89e-07	7.02e-06	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTGS2—prostate cancer	7.82e-07	6.95e-06	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3CA—prostate cancer	7.3e-07	6.49e-06	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTEN—prostate cancer	6.82e-07	6.06e-06	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—EP300—prostate cancer	6.5e-07	5.78e-06	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AKT1—prostate cancer	5.96e-07	5.3e-06	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.81e-07	4.28e-06	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AKT1—prostate cancer	3.93e-07	3.5e-06	CbGpPWpGaD
